Manus Aktteva
We are only a phone call away, Call us on: +91 79 65123395
+91 79 26463395
Home
About Us Pharmaceutical Ingredients, Active Pharmaceutical Rawmaterials, API, Intermediate, Nutraceuticals, Intermediates, Speciality chemicals, Advance level intermediatesEventsNewsEnquiryContact UsResources
Darifenacin Hydrobromide, 133099-07-7, Darifenacin, 133099-04-4, Darifenacin Hydrobromide and its intermediates
Products A to Z
       
Search The Site
Please enter all or part of your keyword to retrive data
Search by: Chemical Name
  CAS#
  Molecular Formula
Quick Help
Services
Queries
Tel1: +91 79 65123395
Tel2: +91 79 26463395
Email: click here
Twitter  Facebook
Darifenacin Hydrobromide
Darifenacin Hydrobromide
Darifenacin works by blocking the M3 muscarinic acetylcholine receptor, which is primarily responsible for bladder muscle contractions. It thereby decreases the urgency to urinate. It should not be used in people with urinary retention. It is not known whether this selectivity for the M3 receptor translates into any clinical advantage when treating symptoms of overactive bladder syndrome.
Product Reference ID: MA-BB-496-O
Chemical Name: (S)-2-{1-[2-(2,3-dihydrobenzofuran-5-yl)ethyl]-3-pyrrolidinyl}-2,2-diphenylacetamide hydrobromide
Description
CAS number 133099-07-7
Synonym (S)-2-{1-[2-(2,3-dihydrobenzofuran-5-yl)ethyl]-3-pyrrolidinyl}-2,2-diphenylacetamide hydrobromide
Molecular Formula C28H30N2O2.HBr.
Molecular Weight 507.5.
Specifications NLT 99%, Detailed specifications available on request
Packing Export worthy Packing
Application A potent muscarinic receptor antagonist.
Material Safety Data Sheet
Available on request
Availability For pilots and commercials
Drug Master File Under process
Comments NMR spectrum data, Method of analysis and tech pack available with shipment
Back to Previous Page Click here to Inquire
Are you looking for Darifenacin Hydrobromide Intermediates ? Please click here to browse through the list of Darifenacin Hydrobromide Intermediates available with us.
Advertisement
NOTE: 
  • Manus Aktteva Biopharma LLP, India is successfully representing suppliers, manufacturers from INDIA, suppliers, manufacturers from CHINA, and fulfilling the requirements of buyers from EUROPE, USA, South America, Japan, Korea, Taiwan, Australia, & middle-east.
       Keywords: New Molecules, patents, R&D, cas, cas number, product, supplier, suppliers, vendor, vendors, price, prices, api, apis, active pharmaceutical ingredient, ingredients, importer, exporter, distributor, import, export, sale, producer, manufacturer, synthesizer, synthesis, gmp, cgmp, fda, dmf, cgmp, cos, inventory, stock, prompt shipment, compounding, compound, research, development, patent, r and d, pharma
  • Please note that products falling in to controlled substance category shall be exported directly from the manufacturer principals only against receipt of original import permission issued by concerned authorities of the importing country.
PATENTS: 
  • => Products protected by valid patents are not offered for sale in countries where the sale of such products constitutes a patent infringement and its liability is at buyer's risk.
        => Products currently covered by valid US Patents are offered for R&D use in accordance with 35 USC 271 +A13(1)
© 2018 MANUS AKTTEVA  All rights reserved..
Payment Procedure